penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Eduardo Rodriguez, M.D.
General Surgery Resident

 
  • Profile Home
  • Appointments
  • Education
  • Memberships
  • Research
  • Publications

Office:
Department of Surgery
4 Maloney
3400 Spruce Street
Philadelphia, PA 19104

Administrative Telephone: 215-662-6156

Contact Information (internal use only)

eduardo.rodriguez@uphs.upenn.edu

 

Dr. Rodriguez is a PGY-7 general surgery chief resident pursuing a career in vascular surgery.  He completed a 2 year post-doctoral research fellowship in the Harrison Department of Surgical Research at the University of Pennsylvania under the direction of Dr. Ali Naji. He studied B-lymphocyte tolerance after organ transplantation, as well as therapeutic strategies to prevent chronic allograft vasculopathy. During his research years  he also worked on angiogenesis with Dr. Emile Mohler.

Eduardo is planning to go to University of South Florida for a Vascular Surgery Fellowship in 2014 when he completes his general surgery training.

 
Appointments

2007 - present

Assistant Instructor in Surgery

 

2010 - 2012

Postdoctoral Researcher

 
 
 
 
 
 
 
Education/Training
2004 MD – Universidad Central de Venezuela
Luis Razetti School of Medicine, Caracas, Venezuela
 
2007 – 2008 Internship, Department of Surgery
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
2008 - present Resident, Department of Surgery
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
Memberships/Societies
  • Resident and Associate Society
  • American College of Surgeons
 
 
 
 
 
 
 
 
Research
2010 - 2012 Post-doctoral Researcher
Humane Genome Sciences, Inc
BLyS Neutralization for Induction of Humoral Transplantation Tolerance
Mentor: Ali Naji, M.D., Ph.D.; Hooman Noorchashm, M.D., Ph.D.
Harrison Department of Surgical Research, Department of Surgery
University of Pennsylvania
Philadelphia, PA
 
2010 - 2012 Post-doctoral Researcher
The role of therapeutic angiogenesis in peripheral artery disease:
In vivo electroporation of HIF-1α plasmid DNA in mouse model of limb ischemia
                         
Mentor: Emile Mohler III, MD
Division of Cardiovascular Medicine, Department of Medicine
University of Pennsylvania
Philadelphia, PA
 
Publications
Peer Reviewed Manuscripts
  1. Redfield RR, Parsons RF, Rodriguez E, Mustafa M, Cassuto J, Vivek K, Noorchashm H, Naji A, Levine MH, Abt PL. Underutilization of A2 ABO incompatible kidney transplantation. Clin Transplant. 2012 May-Jun;26(3):489-94.
  2. Parsons RF, Redfield RR 3rd, Rodriguez E, Mustafa MM, Vivek K, Murayama M, Naji A, Noorchashm H. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance. Semin Immunol. 2012 Apr;24(2):109-14.
  3. Redfield RR 3rd, Rodriguez E, Parsons R, Vivek K, Mustafa MM, Noorchashm H, Naji A. Essential role for B cells in transplantation tolerance. Curr Opin Immunol. 2011 Oct;23(5):685-91.
  4. Vivek K, Mustafa MM, Rodriguez E, Redfield RR 3rd, Parsons RF, Rostami S, Migone TS, Cancro MP, Naji A, Noorchashm H. Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance. Immunol Res. 2011 Oct;51(1):1-4.
  5. Rodriguez E, Ouma G, Muthumani K, Weiner D, Wilensky RL, MD, Mohler III ER. In Vivo Electroporation of Constitutively Expressed HIF-1α Plasmid DNA Improves Limb Perfusion, Salvage, and Functional Capacity in Mouse Model of Limb ischemia. Journal of Vascular Surgery.— 2013 Jul (published online, in press)
Abstracts/Presentations
  1. Rodriguez E, Rostami S, Mustafa M, Parsons R, Vivek K, Redfield R, Devalaraja S, Murayama M, Koeberlein B, Migone T, Cancro M, Naji A, Noorchashm H. BLyS Neutralization Abrogates Humoral Autoimmunity in a Chronic Heart Allograft Rejection Model. American Transplant Congress. 2012.
  2. Noorchashm, Hooman, Rodriguez, Eduardo, Parsons, Ronald, Rostami, Susan Y., Reed, Amy J.,Cancro, Michael P., Naji, Ali. Humoral Tolerance to Murine Cardiac Allografts by Targeting the Critical Homeostatic Regulator of B-lymphocyte Selection, BLyS-BAFF. Accepted for American Association of Thoracic Surgery annual meting 2014.
  3. Rodriguez E, Redfield R, Luo Y, Mustafa M, Rostami S, Devalaraja S, Murayama M, Parsons R, Abt P, Noorchashm H, Naji A. Anti-IL-5 Immunotherapy Depletes Alloreactive Plasma Cells. American Transplant Congress. 2012.
  4. Mustafa M, Vivek K, Ziaie A, Devalaraja S, Rostami S, Luo Y, Rodriguez E, Murayama M, Naji A. Inhibition of Autophagy Reduces Donor Specific Alloantibody in a Murine Skin-Allograft Model. American Transplant Congress. 2012.
  5. Rodriguez E, Redfield RR, Vivek K, Mustafa MM, Naji A, Noorchashm H. Dysregulated B Lymphocyte Tolerance to Self-Antigens Results from Cardiac Allograft Rejection. American Transplant Congress. 2011.
  6. Redfield RR, Parsons RF, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL. Bortezomib Alone Is Sufficient To Eliminate Plasma Cells and Donor-Specific Antibody in Mice. American Transplant Congress. 2011.
  7. Redfield RR, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL., Parsons RF, RANKL-Directed Immunotherapy Reduces Donor Specific Antibodies in Sensitized Mice. American Transplant Congress. 2011.
  8. Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. B-Lymphocyte Directed Immunotherapy at the Time of Induction Is Insufficient for the Establishment of Humoral Transplantation Tolerance. American Transplant Congress. 2011.
  9. Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. BLyS-Directed Immunotherapy Purges Alloreactive Specificities from the Primary B-Cell Repertoire and Promotes Humoral Transplantation Tolerance. American Transplant Congress. 2011.
  10. Parsons RF, Redfield RR 3rd, Rodriguez E, Mustafa MM, Vivek K, Murayama M, Naji A, Noorchashm H. Primary B cell repertoire remodeling to achieve humoral transplantation tolerance. Semin Immunol. 2012 Apr;24(2):109-14.
  11. Redfield RR 3rd, Rodriguez E, Parsons R, Vivek K, Mustafa MM, Noorchashm H, Naji A. Essential role for B cells in transplantation tolerance. Curr Opin Immunol. 2011 Oct;23(5):685-91.
  12. Vivek K, Mustafa MM, Rodriguez E, Redfield RR 3rd, Parsons RF, Rostami S, Migone TS, Cancro MP, Naji A, Noorchashm H. Strategies for B-lymphocyte repertoire remodeling in transplantation tolerance. Immunol Res. 2011 Oct;51(1):1-4.
  13. Rodriguez E, Ouma G, Muthumani K, Weiner D, Wilensky RL, MD, Mohler III ER. In Vivo Electroporation of Constitutively Expressed HIF-1α Plasmid DNA Improves Limb Perfusion, Salvage, and Functional Capacity in Mouse Model of Limb ischemia. Journal of Vascular Surgery.— 2013 Jul (published online, in press)
Abstracts/Presentations
  1. Rodriguez E, Rostami S, Mustafa M, Parsons R, Vivek K, Redfield R, Devalaraja S, Murayama M, Koeberlein B, Migone T, Cancro M, Naji A, Noorchashm H. BLyS Neutralization Abrogates Humoral Autoimmunity in a Chronic Heart Allograft Rejection Model. American Transplant Congress. 2012.
  2. Noorchashm, Hooman, Rodriguez, Eduardo, Parsons, Ronald, Rostami, Susan Y., Reed, Amy J.,Cancro, Michael P., Naji, Ali. Humoral Tolerance to Murine Cardiac Allografts by Targeting the Critical Homeostatic Regulator of B-lymphocyte Selection, BLyS-BAFF. Accepted for American Association of Thoracic Surgery annual meting 2014.
  3. Rodriguez E, Redfield R, Luo Y, Mustafa M, Rostami S, Devalaraja S, Murayama M, Parsons R, Abt P, Noorchashm H, Naji A. Anti-IL-5 Immunotherapy Depletes Alloreactive Plasma Cells. American Transplant Congress. 2012.
  4. Mustafa M, Vivek K, Ziaie A, Devalaraja S, Rostami S, Luo Y, Rodriguez E, Murayama M, Naji A. Inhibition of Autophagy Reduces Donor Specific Alloantibody in a Murine Skin-Allograft Model. American Transplant Congress. 2012.
  5. Rodriguez E, Redfield RR, Vivek K, Mustafa MM, Naji A, Noorchashm H. Dysregulated B Lymphocyte Tolerance to Self-Antigens Results from Cardiac Allograft Rejection. American Transplant Congress. 2011.
  6. Redfield RR, Parsons RF, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL. Bortezomib Alone Is Sufficient To Eliminate Plasma Cells and Donor-Specific Antibody in Mice. American Transplant Congress. 2011.
  7. Redfield RR, Luo Y, Rostami S, Vivek K, Rodriguez E, Mustafa MM, Noorchashm H, Naji A, Abt PL., Parsons RF, RANKL-Directed Immunotherapy Reduces Donor Specific Antibodies in Sensitized Mice. American Transplant Congress. 2011.
  8. Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. B-Lymphocyte Directed Immunotherapy at the Time of Induction Is Insufficient for the Establishment of Humoral Transplantation Tolerance. American Transplant Congress. 2011.
  9. Vivek K, Rostami S, Mustafa M, Rodriguez E, Redfield RR, Luo Y, Ziaie S, Parsons, RF, Migone TS, Cancro MP, Naji A, Noorchashm.H. BLyS-Directed Immunotherapy Purges Alloreactive Specificities from the Primary B-Cell Repertoire and Promotes Humoral Transplantation Tolerance. American Transplant Congress. 2011.

Dr. Eduardo Rodriguez

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine